Development of a Surveillance System for Methicillin-ResistantStaphylococcus aureusin German Hospitals
- 1 April 2007
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 28 (4) , 446-452
- https://doi.org/10.1086/513444
Abstract
Objective.: To determine the appropriate method to calculate the rate of methicillin-resistantStaphylococcus aureus(MRSA) infection and colonization (hereafter, MRSA rates) for interhospital comparisons, such that the large number of patients who are already MRSA positive on admission is taken into account.Design.: A prospective, multicenter, hospital-based surveillance of MRSA-positive case patients from January through December 2004.Setting.: Data from 31 hospitals participating in the German national nosocomial infections surveillance system (KISS) were recorded during routine surveillance by the infection control team at each hospital.Results.: Data for 4,215 MRSA-positive case patients were evaluated. From this data, the following values were calculated. The median incidence density was 0.71 MRSA-positive case patients per 1,000 patient-days, and the median nosocomial incidence density was 0.27 patients with nosocomial MRSA infection or colonization per 1,000 patient-days (95% CI, 0.18-0.34). The median average daily MRSA burden was 1.13 MRSA patient-days per 100 patient-days (95% CI, 0.86-1.51), with the average daily MRSA burden defined as the total number of MRSA patient-days divided by the total number of patient-days times 100. The median MRSA-days–associated nosocomial MRSA infection and colonization rate, which describes the MRSA infection risk for other patients in hospitals housing large numbers of MRSA-positive patients and/or many patients who were MRSA positive on admission, was 23.1 cases of nosocomial MRSA infection and colonization per 1,000 MRSA patient-days (95% CI, 17.4-28.6). The values were also calculated for various MRSA screening levels.Conclusions.: The MRSA-days–associated nosocomial MRSA rate allows investigators to assess the extent of MRSA colonization and infection at each hospital, taking into account cases that have been imported from other hospitals, as well as from the community. This information provides an appropriate incentive for hospitals to introduce further infection control measures.Keywords
This publication has 25 references indexed in Scilit:
- Estimation of methicillin-resistant Staphylococcus aureus transmission by considering colonization pressure at the time of hospital admissionJournal of Hospital Infection, 2005
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBLE) in Northern France: a five-year multicentre incidence studyJournal of Hospital Infection, 2002
- Surveillance and Control of Methicillin-ResistantStaphylococcus aureusInfections in French HospitalsInfection Control & Hospital Epidemiology, 2001
- Global Consensus Conference: Final recommendationsAmerican Journal of Infection Control, 1999
- Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen EinrichtungenBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 1999
- Methicillin-ResistantStaphylococcus Aureusin French Hospitals: A 2-Month Survey in 43 Hospitals, 1995Infection Control & Hospital Epidemiology, 1999
- Nosocomial infection rates in adult and pediatric intensive care units in the United StatesThe American Journal of Medicine, 1991
- Surveillance by objective: A new priority-directed approach to the control of nosocomial infections The national foundation for infectious diseases lectureAmerican Journal of Infection Control, 1985